Hyperparathyroidism Clinical Trial
Official title:
A Novel Approach to Ultrafast Parathyroid SPECT Imaging Using a Solid State CZT SPECT Camera
Purpose of this study is to compare the image quality and diagnostic accuracy obtained with ultrafast solid state short SPECT in comparison with the routine SPECT protocol.
Single-tracer, dual-phase Tc-MIBI parathyroid scintigraphy is based on the differential
washout rate of the tracer (MIBI) from the thyroid and the parathyroid tissue. A distinct
focus of increased MIBI uptake relative to the thyroid gland, either on the early or late
image or on both, or a focal uptake in the mediastinum, is considered positive for abnormal
parathyroid tissue. Tc99m-MIBI planar scintigraphy was found to play a major role in the
preoperative localization of a parathyroid adenoma (PTA), with a sensitivity ranging from
85% to 95% and specificity of up to 99%. Subsequently, the use of MIBI- Single photon
emission computed tomography (SPECT) significantly improved the sensitivity of the test and
improved the accuracy of lesion localization.
A limitation of adding the SPECT component is related to its relatively long duration. The
duration of a MIBI-SPECT acquisition of neck and the mediastinal area may take up to 15-20
minutes using a standard nuclear medicine camera. Long acquisition time may lead to patient
discomfort and movement resulting in image degradation, artifacts and may lead to overall
decreased diagnostic accuracy.
A reduced SPECT acquisition time without image quality degradation may decrease patient
discomfort and increase clinical throughput. An ultrafast solid state CZT camera (GE
Healthcare Discovery 570C) is currently used for routine cardiac SPECT imaging achieving
high quality cardiac studies for a significantly shorter acquisition time. Present study
evaluates the potential use of the ultrafast camera in patients with a clinically suspected
PTA who perform Tc-MIBI imaging.
;
Observational Model: Case-Only, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00377312 -
7 Day Continuous Parathyroid Hormone IV Infusion
|
Phase 0 | |
Completed |
NCT00379899 -
ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
|
Phase 4 | |
Completed |
NCT04040946 -
Trial Comparing 2 Diagnostic Strategies for Preoperative Localization of Parathyroid Adenoma in Primary Hyperparathyroidism:TEMP / CT With Tc99m-sestaMIBI or PET / CT With F18-choline in First Intention
|
Phase 3 | |
Recruiting |
NCT03053999 -
Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)
|
||
Withdrawn |
NCT02711059 -
Insulin Resistance in Primary Hyperparathyroidism
|
N/A | |
Completed |
NCT01691781 -
The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study
|
N/A | |
Completed |
NCT00538720 -
Effects of Vitamin D Replacement in Patients With Primary Hyperparathyroidism (PHPT)
|
Phase 1 | |
Completed |
NCT00887666 -
Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure
|
N/A | |
Terminated |
NCT03044600 -
Gene Expression in Hyperparathyroidism
|
||
Completed |
NCT03747029 -
Serum Calcium to Phosphorous (Ca/P) Ratio in the Diagnosis of Ca-P Metabolism Disorders: a Multicentre Study
|
||
Completed |
NCT01872429 -
Short- and Long-Term Impact of Subtotal Parathyroidectomy on the Achievement of Bone and Mineral Parameters Recommended by Clinical Practice Guidelines in Dialysis Patients
|
N/A | |
Completed |
NCT00800358 -
Safety and Efficacy Study of Paricalcitol Versus Calcitriol in the Treatment of Secondary Hyperparathyroidism
|
N/A | |
Recruiting |
NCT00169806 -
Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis
|
N/A | |
Completed |
NCT03968510 -
Swalqol in Primary Hyperparathyroidism
|
||
Completed |
NCT00501215 -
Effect of Parathyroidectomy on Sleep
|
N/A | |
Completed |
NCT02591160 -
Optimal HCTZ Cessation for Diagnosis of Hyperparathyroidism
|
N/A | |
Recruiting |
NCT05299632 -
F-18 PSMA for Localization of Parathyroid Adenoma
|
||
Recruiting |
NCT02986607 -
Corticosteroid Rhythms in Hypoparathyroid Patients
|
Early Phase 1 | |
Completed |
NCT02432599 -
Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid Adenomas
|
Phase 2 | |
Completed |
NCT02524041 -
Association Between Serum Periostin Levels and Cortical Porosity in Patients With Secondary Hyperparathyroidism
|
N/A |